Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck Serono Takes Action Against Illegal Online Drug Sales

This article was originally published in PharmAsia News

Executive Summary

Merck Serono China, subsidiary of Germany-based Merck, recently issued a statement revealing that some Chinese websites have been illegally selling drugs using the firm's brand names without its knowledge or permission. None of the drugs sold are developed, produced and marketed by Merck Serono, nor have they obtained the company's sales authorization. The websites and drugs include Moxue-Xianfuan by www.merckdx.com, Moxue-Mianfuan by www.merck-china.net and www.merckchina99.com, and Moxue-Meiluoxin by www.mxmnw.com. Merck Serono China has reported the illicit operations to relevant authorities and demanded severe punishments, with the rights to take further legal actions. (Click here for more - Chinese language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel